The NetSuite Accountant

NetSuite | Fixed Asset rollforward report, part 1

Paul Giese Dec 17, 2019 5:15:00 AM
0

The most common report used around fixed assets is the rollforward. The rollforward shows the beginning balance, additions, disposals, depreciation, and ending balance over a given period. Over the next series of blog posts, I will walk you through how to build saved searches and views to compile a rollforward report in NetSuite.

To start, we are going to customize the fixed asset listing view to calculate the beginning and ending balances for gross assets and accumulated depreciation.

Read More

NetSuite | Common biotech GL account structures

Paul Giese Dec 10, 2019 5:15:00 AM
0

The general ledger (GL) account structure is an art, not a science. Every company has unique reporting requirements. The GL structure is a way to ease reporting requirements. There are good ways and bad ways to structure the GL. Here are a few tips and tricks that I've found after advising several biotech organizations on restructuring their GL during a NetSuite ERP implementation:

Read More

Four ways a procurement system can automate the AP process

Paul Giese Jul 22, 2019 5:15:00 AM
0

Accounts payable is the foundation of a biotech’s financial statements. This role is often filled by entry-level staff with high turnover. This can cause problems for financial reporting. Thankfully, an advanced procurement system, if configured properly, can automate parts of the accounts payable function, ensuring that disruptions have a smaller impact on financial reporting. Here are four configurations that can automate accounts payable:

Read More

Three challenges to prepare for during a procurement implementation

Paul Giese Jul 15, 2019 5:15:00 AM
0

I recently led the implementation of a procurement system at one of my clients. Overall, the project went well, but, like all system implementations, there were some unanticipated challenges. Teams implementing a new purchasing system should plan and anticipate for these three challenges:

Read More

Compt | Meaningful and Personalized Benefits

Paul Giese Feb 25, 2019 5:30:00 AM
0

The war for biotech talent is fierce. Last Fall, the Boston Globe ran an article discussing the crazy benefits that early-stage biotechs offer to keep and retain employees. Benefits, such as boxing classes or a fully-stocked coffee bar, are great when all employees like boxing or coffee. But, inevitably, when some employees prefer yoga or tea, these benefits result in a workforce where everyone is equally unhappy.

Read More

Better Manage Corporate Cards | Teampay

Paul Giese Jan 28, 2019 5:30:00 AM
0

Corporate credit cards pose a challenge for accounting teams. Employees like corporate cards because they are easy to use. But, companies can easily lose control of spending. And, tracking down receipts is nearly impossible, coding transactions can take hours and there is a lack of real-time analysis. If you can relate to these problems (I can!), read on to learn how Teampay is trying to solve these problems.

Read More

Three Resources for the Biotech Accountant

Paul Giese Jan 2, 2019 7:47:00 AM
0

Within a small organization, accounting can add value to their organization by offering strategic advice on managing resources. Accounting has a unique perspective because it often touches all parts of the organization - research, clinical, human resources and procurement to name a few.

Read More

Five NetSuite Reports For A More Efficient Financial Close

Paul Giese Nov 12, 2018 5:30:00 AM
0

Adding automation to your financial close increases efficiency and reduces the chance for error in your reporting process. When working on a tight SEC deadline for 10-Q and 10-K reporting, every hour saved helps. If using NetSuite as an ERP, below are five custom reports that can improve efficiency in the close process. This article assumes that companies are using the general ledger account, functional department, and class segments in NetSuite.

Read More

Biotech Comparables | Over Time & Point In Time Revenue Under ASC 606

Paul Giese Oct 31, 2018 6:00:00 AM
0

Once the performance obligations in a  biotech collaboration agreement have been identified and revenue has been allocated to each performance obligation, an entity needs to determine whether revenue is recognized at a point in time or over a period of time. There are three criteria to determine if revenue is recognized over a period of time. For biotech companies, the most relevant criteria is whether the company's performance creates or enhances an asset (for example, in process research) that the customer controls as the asset is created or enhanced (criteria 2).

Read More

Budget Considerations for ASC 606 Revenue Recognition

Paul Giese Oct 27, 2018 5:08:43 PM
0

Under ASC606, collaboration revenue is recognized as a company incurs costs to deliver the performance obligation. Companies need to determine the total costs to deliver a performance obligation at the start of the collaboration agreement and make updates as new information becomes available. Because the budget and long-range plan are critical for recognizing revenue, companies will need to ensure that the appropriate processes are in place around these assumptions. Here are four budget considerations in the revenue recognition process:

Read More